Huntsville, Alabama--(Newsfile Corp. - October 23, 2024) - Kalm Therapeutics and CFD Research are pleased to announce a SBIR Phase 2 Grant award from the NIH National Center for Complementary and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback